GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Imagion Biosystems IBX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.01

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2025

Revenue

A$32,370

FY2016FY2025

Net income

−A$4.3m

FY2016FY2025

Free cash flow

−A$4.0m

FY2016FY2025

Shareholders' equity

−A$2.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueA$32,370A$2.7mA$1.1mA$473,429A$232,865A$205,717A$410,854A$191,477A$20,102A$12
Research and developmentA$2.1mA$401,036A$5.3mA$3.6mA$2.7mA$2.9mA$2.3mA$3.3mA$2.2mA$502,070
Operating income−A$3.5m−A$756,553−A$14.9m−A$12.1m−A$8.3m−A$7.8m−A$3.4m−A$8.3m−A$6.9m−A$566,570
Net income−A$4.3m−A$2.1m−A$12.5m−A$9.8m−A$6.0m−A$5.4m−A$3.4m−A$8.3m−A$7.8m−A$1.0m
Diluted earnings per share-0.01-0.04-0.38-0.35-0.01-0.01-0.01-1.41-0.03-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsA$2.0mA$2.8mA$4.6mA$10.0mA$14.1mA$14.1mA$4.9mA$5.2mA$7.6mA$12.1m
Cash and short-term investmentsA$1.8mA$2.7mA$227,084A$4.4mA$13.4mA$13.2mA$3.4mA$4.4mA$6.9mA$11.9m
Total liabilitiesA$4.2mA$5.1mA$8.4mA$5.3mA$809,876A$1.2mA$1.9mA$1.3mA$688,770A$451,993
DebtA$2.6mA$2.8mA$6.0mA$4.6mA$46,021A$660,980A$876,780A$54,516A$80,014A$13.9m
Shareholders' equity−A$2.2m−A$2.3m−A$3.8mA$4.7mA$13.3mA$12.9mA$3.0mA$3.9mA$7.0mA$11.7m
Shares outstanding364m57m33m28m1,121m998m542m6m234m184m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−A$4.0m−A$1.3m−A$8.3m−A$8.1m−A$5.1m−A$4.6m−A$4.2m−A$8.1m−A$7.0m−A$267,256
Capital spending−A$4−A$1−A$190,379−A$507,315−A$218,833−A$7,860−A$12,353−A$83,565−A$369,606−A$369,606
Free cash flow−A$4.0m−A$1.3m−A$8.5m−A$8.6m−A$5.3m−A$4.6m−A$4.2m−A$8.2m−A$7.3m−A$636,862
Dividends paid————−A$359,252−A$480,624−A$35,395—−A$294,544—

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue—A$6,640A$25,734A$1.0mA$1.6mA$817,524A$746,669A$2.1m
Operating income−A$2.3m−A$2.4m−A$1.8mA$114,610−A$871,166−A$435,583−A$8.1m−A$2.3m
Net income−A$2.0m−A$2.6m−A$1.7m−A$540,128−A$1.5m−A$763,415−A$4.8m−A$2.4m
Diluted earnings per share-0.00-0.01-0.00-0.01-0.03-0.01-0.15-0.07
Cash from operations−A$1.0m−A$2.0m−A$1.0m−A$1.0m——−A$2.0m−A$1.0m
Total assetsA$671,925A$2.0mA$932,475A$2.8mA$522,723A$522,723A$4.6mA$4.6m
Cash and short-term investmentsA$32,456A$1.8mA$883,565A$2.7mA$382,450A$382,450A$227,084A$227,084
DebtA$2.2mA$2.6mA$3.3mA$2.8mA$3.2mA$3.2mA$6.0mA$2.8m
Shareholders' equity−A$3.4m−A$2.2m−A$3.9m−A$2.3m−A$5.3m−A$5.3m−A$3.8m−A$3.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-59.1%-30.9%19.4%
Operating income-33.7%-14.5%-1.5%
Net income-24.0%-4.3%-0.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-159.1%-737.6%-1011.2%-1329.9%
Net margin-236.4%-673.7%-853.5%-1222.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-2.1-0.6-0.6-1.8-366.0-698.5-60.2-0.2-28.0
Price to sales280.90.56.936.8———8.8—

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 40-to-1 reverse split · 16 Nov 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.